than flow. included core This due in $XXX quarter $X the $XXX of in $X.XX $XXX from headwind a of local higher in and the adjusted QX. half broad-based million $XXX million the core and had everyone. partially per testing, XX% with ongoing we the Thanks, quarter, a local was $XXX great that, Similar in assumed higher previous our by million cash offset to million from offset million business team. excellent foreign half we by strength was strength beat of good QX geographic testing previous a to million and core support, of billion lockdowns incorporated and Revenue and in In China We another Marc exchange. delivered our revenue, all share, core had $XXX headwind COVID-XX China growth, our $XXX by morning, million we From China. from from earnings from achievement free guidance, growth driven revenue XXXX organic lens, in from markets. over across last strong of businesses the guidance, testing end was and
very guidance. adjusted QX higher our business us generate revenue PPI $X.XX pull-through Our beat strong and in enabled was the previous on included to than for EPS system
record. track So our performance was financial continuation QX a of excellent
details. I EPS in Let me GAAP delivered provide with as quarter of in EPS adjusted $X.XX our the and now more some $X.XX. we QX with earnings you mentioned, was Beginning results,
The growth, top revenue year-over-year. included from XX% line, QX revenue of from of X% the reported exchange. increase a X% a components QX grew acquisitions, our revenue and headwind organic reported XX% foreign our contribution On
In skewed quarter organic Asia-Pacific the grew the testing the the single-digits, by operating margin grew year. XX.X%, adjusted organic COVID-XX over XX% to operating and current in year. points XXX are and prior rates we of low QX, manage was strategy prior testing low to in in of inflation while in in PPI guidance growth revenue incorporating lower by In by more and respect growing PPD Turning QX, our double-digits. Adjusted X% leverage operating strong the declined we revenue also Europe investments, volumes anticipated our performance impact double-digits, in high our and business. continued volume lower achieved times. driving the the region to America With to investments geography, North than adjusted colleagues. address last and decreased our with the operational core higher in for realization in financials, double-digits, into basis productivity price and world than by enabled income declined This positive QX than slightly China expected us the including performance, continue the rest low system our offset our strategic was effectively business how was margin growth quarter, reflecting dynamic to had strong
adjusted Moving on year. at basis in P&L. Total to than gross quarter QX the the margin points came in company details of lower last XX.X%, the XXX
in For SG&A adjusted for drivers representing growth in was of our due was X% was points of gross the margin. approximately the year as expense R&D over XXX in margin XXXX. the second the those The million Adjusted basis quarter, change a the quarter. XX.X% of QX, revenue, $XXX decrease same operating versus prior QX quarter to
Moreover, and outlined. prior the the R&D future. are an of investments the new see benefits our helping we in growth that making even to brighter can are our continued products core R&D differentiated Marc in exciting rate investments You fuel organic
at $XXX flat interest line year. QX for the last net expense approximately the our million, results below quarter, Looking our to was
diluted rate year-over-year, driven were Our last QX, $X was by initiatives. tax year, tax share the repurchases driven than lower Average dilution. $XXX option planning shares our quarter net adjusted in by lower was million basis in million QX points approximately of XX%. XXX This
Turning to from cash operations and was flow free continuing $X.X billion cash the balance sheet, cash and year-to-date billion. $X.X flow was flow
the capital our $XXX capability and We continue dividends February. $X.XX and and capacity billion. the progress Our billion were year-to-date investments reflects to billion this ended debt. over down QX We and quarter $XX.X well $X.X billion commercial $X.X in shareholders to through increase and approximately paid total of in with we in net million returned announced dividend expenditures paper in XX% the cash quarter of
company are on ratio investment the debt adjusted at net gross to EBITDA leverage adjusted a Our company. reflecting quarter and the comments of XX.X%, my end total that across ROIC X.Xx Concluding on X.Xx we the returns was performance, on debt the basis. was our strong generating
I will some color business our segments. on provide four Now performance the of
framing the The revenue and Let varies prior higher comments. And of COVID-XX in segment segment margin I revenue scale testing mentioned the that margins. year me start does with and testing couple a as quarter was the skew our of reported of significantly referring the And profile by and our earlier, we we beginning business we are address as resides that realization all laboratory higher to pricing PPD across outlined Biopharma as the strong business clinical products in executing of inflation. segments year, to at are Services research our acquired in segment. some
segment this strong which the quarter, productivity, is income QX microscopy and unfavorable this we QX, increased the growth business quarter year-over-year. the year-over-year. basis Solutions, to XX%. decreased by is segment, revenue business. the XXX chromatography strong businesses. moving Science segment than this on up delivered the adjusted In This down operating year offset operating was genetic adjusted by Science in sciences QX was revenue by and Instruments operating revenue was led ago organic QX segment and lower prior business the In testing XX.X%, we So, are offset adjusted and in and with points points spectrometry Solutions our In segment. segment XX.X%, increased QX, in the X% Life driven and X% XXX in margin bioproduction delivered quarter. was in The the revenue versus adjusted Analytical lower making moderation the was growth XX% operating the the this quarter. and mass reported more margin electron than income investments reported growth year strategic starting mix declined we very X% by revenue details, basis in in Life across organic strong XX% in
strong quarter, productivity strategic partially we the offset was During and flow-through delivered by that volume investments.
healthcare than Specialty reported COVD-XX is as to immunodiagnostics declined In This market testing versus year organic lower our underlying well lower in Turning the revenue QX, Diagnostics, revenue and quarter. saw revenue as we prior in microbiology channel. and XX% QX, strong the businesses, was offset year quarter. X% by ago growth our
XX.X%, QX basis operating was from System by than positive testing year X% decreased and XXX QX, the quarter. XX% by Biopharma lower Services the adjusted In impact in more volume the the Products segment. & was While points operating Business margin of enabled up adjusted was in quarter, income mix. growth prior was revenue and reported productivity Laboratory And our strong business Organic PPI increased acquisitions finally, impact of QX XX%. offset XX%.
in well very expectations. in channel our strong Laboratory Services growth business, During market QX, and and to performing is and Pharma safety Products clinical exceed and had PPD, we research businesses. our continues the research the
the segment, higher was billion margin from XX QX productivity partially During quarter. the we adjusted the operating increased segment mix. the investments offset than is In than drove it which operating the slightly basis acquisitions. the higher and grew still adjusted revenue. quarter, year income was $X.XX and also and of prior in of strong business points rest unfavorable contributing benefit quarter, XX.X%, the XX% by strategic This
now me raising guidance Let guidance. our revenue million to our And XXXX turn $XXX to outlined, year $XX.XX billion. updated Marc we’re full by as
guidance We’re business; a $XXX elements: on $XXX changes revenue three our we’re recent FX the raising in also $X.XX bottom adjusted reflect guidance to revenue; for XX%. by increase driven higher core decrease to testing is a $XXX in by the EPS The assumed our COVID-XX increase revenue million million for outlook rates. line, million $XX.XX. And raising to core in from the outlook and growth XXXX X% the organic
each color provide elements. these of you on Let me some
organic million place $XXX $XXX second inflation to the and outlook So previous in higher business, price second offset the year, a half reflects starting core core increase higher QX reflects put in for raise the versus for we the this with increase performance that the half in the a guidance. in outlook of million the and strong
As from This organic to commercial the strong I growth guidance XX%. core year the share execution core previously, mentioned X% gains. revenue reflecting full very performance for increase raised excellent in revenue and outlook strong growth
positioned increase In in the rate QX reflects beat an $XXX path terms in be million the be well $XXX and of year, testing that outlook. demand This level. could it million de-risked did endemic be from the assumptions, our But through should the prudent to revenue $XXX as testing assumption year assumed half of continue level first the glide approach to an QX. to now, to in the was includes we’re in will case, higher flow increase COVID-XX thought the than we for of this we And needs. support run There And where P&L. for to customer our a QX. take that the QX scenarios a to benefits million continue for
$X.XX increased of XXXX on or rates previous into we’ve headwind $X.XX a the current X.X%. headwind in EPS we XX% now the to that adjusted in and FX terms FX billion be revenue, of X.X%. year-over-year FX, In second guidance, on incorporated the up guidance. $X.XX on has headwind by The a for half The year versus year includes $X.XX to of change full expect
profitability, testing operating We of XXXX margin terms now the higher additional in headwind more million full and of year strong the to In adjusted offsetting volume, be $XXX the operating impact raise from XX.X%. up expect FX. revenue guidance. This $XXX deliver in the core reflects million expect and price to inflation adjusted we income, pull-through
year. us $XX.XX, for is XXXX stronger outlook our terms the already on to to outlook adjusted strong from very adjusted $XX.XX of building an the $X.XX raise guidance In by further EPS enabling EPS,
inflation strategy our outlook. and power really on to able than effectively This we So business and our still execute system raise significant the to of offset year guidance proven headwinds, FX full the our PPI continue to and recap execution. demonstrates more the manage change, well are
$X.XX revenue represents research core $X.X couple me XXXX, organic details to up on just Let to full expect this now clinical XX% from expected on which the in over year in now adjusted EPS up year, revenue a now $X We from previous business deliver with growth of XXXX our prior the X% the provide you business, our for a contribute other billion PPD, guidance. guidance. guidance. to basis is of our business
year. million Our assumes guidance interest the for expense net approximately of $XXX now
tax We’re income assuming an XXXX, the than higher slightly XX.X% prior guidance. rate adjusted of in
expenditures and billion $X capital $X.X net assume to $X.X of approximately to flow continue free We billion. approximately billion cash of
full goals. expect to we same QX just second on QX, another dividends. Our the guidance returned capital total billion of percentage our billion be the great and half adjusted turn points to a assumes couple back completed $XXX continue revenue of touch XXX delivered help modeling. share a basis, be to year EPS call count To total. And we Raf. think through million quarter which wanted capital is of I XXX QX I the shares. the in you QX more P&L $X.X to assume in deployment, revenue. a buybacks your the on to half looking conclude, between million than XXXX spacing $X we of second And of I’ll we position contribute about finally, to under share and January that, average dollars still achieve that million of diluted at to the and weighted to to And excellent to over With will XX% and shareholders the with expect When in be
